Evidence map›Paper›PMID 22901255›Full record

ReviewAnnals of the New York Academy of Sciences2012

Caudal genes in blood development and leukemia.

Claudia Lengerke, George Q Daley

Open access · greenAbstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Claudia LengerkeUniversity of Tübingen Medical Center-Hematology & Oncology, Tübingen, Germany. claudia.lengerke@med.uni-tuebingen.de
George Q Daley
Dana-Farber Cancer Institute · USUniversity of Tübingen · DE

Funding

Causal Transcriptional Consequences of Human Genetic VariationP50HG005550 · NHGRI · HARVARD MEDICAL SCHOOL · PI CHURCH, GEORGE M · 2010 to 2014
$19.0M
Customized stem cells for clinical application in blood disordersR24DK092760 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI COLLINS, JAMES J, DALEY, GEORGE Q · 2011 to 2018
$10.7M
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood DiseasesU01HL100001 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI DALEY, GEORGE Q, ORKIN, STUART H · 2009 to 2015
$8.9M
Novel therapies for Fanconi anemiaRC4DK090913 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI D'ANDREA, ALAN D., DALEY, GEORGE Q · 2010 to 2010
$3.9M
Murine Models for Regenerative MedicineR01DK070055 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI DALEY, GEORGE Q · 2005 to 2009
$3.5M
Comparative phenotypic, functional, and molecular analysis of ESC and iPSCRC2HL102815 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI CHURCH, GEORGE M, COLLINS, JAMES J · 2009 to 2010
$3.4M
Hematopoietic stem cells from totipotent stem cell typesR01DK059279 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI DALEY, GEORGE Q · 2001 to 2009
$3.3M
Howard Hughes Medical InstituteNHGRI NIH HHS P50 HG005550NHGRI NIH HHS P50HG005550NHLBI NIH HHS RC2 HL102815NHLBI NIH HHS RC2-HL102815NHLBI NIH HHS U01 HL100001NHLBI NIH HHS U01-HL100001NIDDK NIH HHS R01 DK059279NIDDK NIH HHS R01 DK070055NIDDK NIH HHS R24 DK092760NIDDK NIH HHS R24DK092760NIDDK NIH HHS RC4 DK090913NIDDK NIH HHS RC4-DK090913
6 · The paper itself

Abstract

Members of the caudal gene family (in mice and humans: Cdx1, Cdx2, and Cdx4) have been studied during early development as regulators of axial elongation and anteroposterior patterning. In the adult, Cdx1 and Cdx2, but not Cdx4, have been intensively explored for their function in intestinal tissue homeostasis and the pathogenesis of gastrointestinal cancers. Involvement in embryonic hematopoiesis was first demonstrated in zebrafish, where cdx genes render posterior lateral plate mesoderm competent to respond to genes specifying hematopoietic fate, and compound mutations in cdx genes thus result in a bloodless phenotype. Parallel studies performed in zebrafish embryos and murine embryonic stem cells (ESCs) delineate conserved pathways between fish and mammals, corroborating a BMP/Wnt-Cdx-Hox axis during blood development that can be employed to augment derivation of blood progenitors from pluripotent stem cells in vitro. The molecular regulation of Cdx genes appears complex, as more recent data suggest involvement of non-Hox-related mechanisms and the existence of auto- and cross-regulatory loops governed by morphogens. Here, we will review the role of Cdx genes during hematopoietic development by comparing effects in zebrafish and mice and discuss their participation in malignant blood diseases.

Indexed as

Genes, HomeoboxAdultAdult Stem CellsAnimalsCDX2 Transcription FactorHematopoiesisHematopoietic Stem CellsHomeodomain ProteinsHumansLeukemiaMiceMice, KnockoutModels, GeneticMultigene FamilyPluripotent Stem CellsSignal TransductionCDX1 protein, humanCDX2 protein, humanCDX2 Transcription FactorHomeodomain ProteinsTretinoin

Identifiers

PMID22901255
PMCPMC3431192
OpenAlexW2152603718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.